Anna L. Gray

Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1^G93A mouse model of ALS

Bernadett Kalmár, Sergey S. Novoselov, Anna L. Gray et al. · Journal of Neurochemistry · 2008 · 161 citations

Cell Death, Synaptic Signaling, Social Sciences +19

A comprehensive assessment of the <i>SOD1G93A</i> low-copy transgenic mouse, which models human amyotrophic lateral sclerosis

Abraham Acevedo‐Arozena, Bernadett Kalmár, Shafa Essa et al. · Disease Models & Mechanisms · 2011 · 105 citations · Full text

Knockout Mouse, Neurodegenerative Diseases, Comprehensive Assessment +15

Graphene active sensor arrays for long-term and wireless mapping of wide frequency band epicortical brain activity

Ramon Garcia‐Cortadella, Gerrit Schwesig, Christoph Jeschke et al. · Nature Communications · 2021 · 91 citations · Full text

Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors

Anna L. Gray, Richard Karlsson, Abigail R. E. Roberts et al. · Cell Reports · 2023 · 70 citations · Full text

Widespread Immune Cell, Chemokine Biology, Immunology +20

Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy

Bilal Malik, Niranjanan Nirmalananthan, Anna L. Gray et al. · Brain · 2013 · 64 citations · Full text

Androgen Receptor, Immunology, Thermal Therapy +16